Management of adenomatous hyperplastic nodules in the cirrhotic liver: US follow-up or percutaneous alcohol ablation? In order to investigate the most appropriate management of adenomatous hyperplastic nodules in cirrhosis (AHNs), retrospective and prospective studies were undertaken. The retrospective study included 11 AHNs detected in nine patients, who were followed with ultrasonography (US) and fine-needle biopsy (FNB) seven of these lesions evolved into hepatocellular carcinoma (HCC) after a mean follow-up period of 11.4 months. The prospective study involved 19 AHNs (in 12 patients) that were submitted to percutaneous ethanol injection (PEI)